schizandrin b has been researched along with Myocardial Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, G; Shao, M; Yang, W | 1 |
| Cai, C; Xiang, Y; Zeng, C; Zhao, X; Zhou, A; Zhu, N | 1 |
| Chen, B; Chen, P; Gao, W; Liu, J; Meng, H; Pang, S; Tao, Z; Wang, L; Xu, Z; Yang, N; Yang, Z; Zhang, M; Zhou, N | 1 |
3 other study(ies) available for schizandrin b and Myocardial Infarction
| Article | Year |
|---|---|
Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
Topics: Animals; Biological Availability; Cardiotonic Agents; Cell Death; Cyclooctanes; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Humans; Lignans; Lipids; Matrix Metalloproteinases; Myocardial Infarction; Nanoparticles; Particle Size; Peptides; Polycyclic Compounds; Polyethylene Glycols; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Tissue Distribution | 2017 |
Schisandrin B protects against myocardial ischemia/reperfusion injury via the PI3K/Akt pathway in rats.
Topics: Animals; Apoptosis; Biomarkers; Creatine Kinase, MB Form; Cyclooctanes; Disease Models, Animal; Lignans; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Troponin T | 2018 |
Beneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction.
Topics: Animals; Apoptosis; Cell Line; Cyclooctanes; Fruit; Humans; Lignans; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Polycyclic Compounds; Rats; Schisandra | 2013 |